Jefferies maintains RxSight at Hold, cuts price target
Jefferies maintained RxSight at Hold while cutting its price target to $5.75 from $6.50.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
RxSight Price Target Cut to $5.50/Share From $6.50 by B of A Securities
Ratings actions from Benzinga